Obesity and metabolic disorders as a risk factor of endometrial hyperplasia, uterine fibroids and adenomyosis
Stanoevich I.V., Kudrina E.A., Zholobova M.N., Masyakina A.V., Kovaleva A.M.
Архив акушерства и гинекологии им. В.Ф. Снегирева
Т. 3, № 3, С. 149-155
Опубликовано: 15 2016
Тип ресурса: Статья
DOI:10.18821/2313-8726-2016-3-3-149-155
Аннотация:
The review deals with the role of endocrine and metabolic deteriorations in the development of overlapping clinically manifested benign hyperplastic lesion of endo- and myometrium. Hyperleptinemia is a powerful potentiating factor of endocrine diseases of the uterus. Modern correction of both endocrine and metabolic disorders is a key component of the comprehensive treatment and prevention of hyperplastic diseases of the uterus.
Язык текста: Русский
ISSN: 2313-8726
Stanoevich I.V.
Kudrina E.A. Elena A.
Zholobova M.N. Mariya N.
Masyakina A.V.
Kovaleva A.M.
Первый МГМУ им. И.М. Сеченова МЗ РФ
I.M. Sechenov First Moscow State Medical University
Obesity and metabolic disorders as a risk factor of endometrial hyperplasia, uterine fibroids and adenomyosis
Текст визуальный электронный
Архив акушерства и гинекологии им. В.Ф. Снегирева
Eco-Vector
Т. 3, № 3 С. 149-155
2016
гиперплазия эндометрия
endometrial hyperplasia
миома матки
uterine fibroids
аденомиоз
adenomyosis
обменно-эндокринные заболевания
metabolic and endocrine diseases
лептин
leptin
Статья
The review deals with the role of endocrine and metabolic deteriorations in the development of overlapping clinically manifested benign hyperplastic lesion of endo- and myometrium. Hyperleptinemia is a powerful potentiating factor of endocrine diseases of the uterus. Modern correction of both endocrine and metabolic disorders is a key component of the comprehensive treatment and prevention of hyperplastic diseases of the uterus.